Product correctly added to cart.

Standards and Solutions in Compliance with Pharmacopoeias
Standards and Solutions in Compliance with Pharmacopoeias

Standards and Solutions in Compliance with Pharmacopoeias

Standards and solutions in compliance with pharmacopoeias are essential reference materials used to ensure the quality, safety, and efficacy of pharmaceutical products. This category includes a wide range of solutions and reagents that adhere to the stringent requirements set forth by various pharmacopoeias, such as the European Pharmacopoeia (EP) and the British Pharmacopoeia (BP). These standards are critical for the calibration and validation of analytical methods, ensuring that pharmaceutical products meet regulatory standards. They support a broad spectrum of applications, including the analysis of active pharmaceutical ingredients (APIs), excipients, and finished drug products. By providing consistent and reliable reference points, these standards and solutions facilitate compliance with regulatory requirements, enhance quality control processes, and ensure the production of safe and effective pharmaceuticals. Their use is indispensable in pharmaceutical research, development, and manufacturing, ensuring that products adhere to the highest quality standards.

Read more

Products of "Standards and Solutions in Compliance with Pharmacopoeias"

Sort by


See more categories

This search does not contain any category.

products per page. 4400 products on this category.

BrandProduct dataPurityPrice rangeEstimated delivery
British Pharmacopoeia logo
Fenofibrate
REF: 47-1280
CAS: 49562-28-9
99.9%242.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Cabazitaxel acetone CRS
REF: 41-Y0002398
CAS: 1426815-65-7
- - -228.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Cabazitaxel for system suitability CRS
REF: 41-Y0002441
CAS: 1426815-65-7
- - -455.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Daunorubicin hydrochloride CRS
REF: 41-D0125000
CAS: 23541-50-6
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Haloperidol decanoate for system suitability CRS
REF: 41-Y0002434
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Propylene glycol for identification CRS
REF: 41-Y0002435
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Salidroside CRS
REF: 41-Y0002423
CAS: 10338-51-9
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Tetracosactide for peak identification CRS
REF: 41-Y0002442
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Daclatasvir dihydrochloride RS
REF: 41-ICRS070001
- - -102.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Vasicine CRS
REF: 41-Y0002397
CAS: 6159-55-3
- - -228.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Pancreas powder (amylase) BRP
REF: 41-Y0001632
CAS: 8049-47-6
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Amiodarone impurity G CRS
REF: 41-Y0002471
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Amiodarone impurity C CRS
REF: 41-Y0002470
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Baclofen impurity E CRS
REF: 41-Y0002474
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Haloperidol decanoate impurity mixture CRS
REF: 41-Y0002439
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Chloroxylenol for system suitability CRS
REF: 41-Y0002463
CAS: 88-04-0
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Platinum solution CRS
REF: 41-Y0002419
CAS: 16941-12-1
- - -To inquireWed 08 Jan 25
EDQM - European Pharmacopoeia logo
Fenticonazole impurity E CRS
REF: 41-Y0002403
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Dextromethorphan for system suitability CRS
REF: 41-Y0002402
CAS: 6700-34-1
- - -115.00 €Wed 08 Jan 25
British Pharmacopoeia logo
Metformin for system suitability
REF: 47-1296
CAS:
- - -211.00 €Wed 08 Jan 25
discount label

Fenofibrate


Ref: 47-1280

100mg242.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002398

120mg228.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002441

10mg455.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Daunorubicin hydrochloride CRS


Ref: 41-D0125000

120mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002434

15mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002435

150mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002423

25mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002442

0.206mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-ICRS070001

210mg102.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002397

15mg228.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Pancreas powder (amylase) BRP


Ref: 41-Y0001632

2000mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002471

0.05mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002470

0.05mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002474

0.001mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002439

0.08mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002463

55mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002419

10ml115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002403

0.004mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002402

10mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 47-1296

10mg211.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".